Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Schmidt

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
European Journal of Pharmacology|September 22, 1992
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamineC J Schmidt, C K Black, V L Taylor, et al.
Animal Genetics|October 13, 2018
FAANG, establishing metadata standards, validation and best practices for the farmed and companion animal communityP W Harrison, J Fan, D Richardson, et al.
Pharmacology, Biochemistry, and Behavior|July 27, 1999
Pyridostigmine bromide alters locomotion and thigmotaxis of rats: gender effectsJ B Hoy, B A Cody, J L Karlix, et al.
Psychopharmacology|January 1, 1993
Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic functionM G Palfreyman, C J Schmidt, S M Sorensen, et al.
Forensic Science International|April 2, 2016
Fluorescently labeled bacteria provide insight on post-mortem microbial transmigrationZ M Burcham, J A Hood, J L Pechal, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studiesS M Sorensen, J H Kehne, G M Fadayel, et al.
Magnetic Resonance in Medicine|April 16, 1999
Measurement of human myocardial perfusion by double-gated flow alternating inversion recovery EPIB P Poncelet, T M Koelling, C J Schmidt, et al.
Neuroscience|September 25, 2012
The distribution of phosphodiesterase 2A in the rat brainD T Stephenson, T M Coskran, M P Kelly, et al.
BMC Genomics|May 28, 2016
Genomic analysis of Ugandan and Rwandan chicken ecotypes using a 600 k genotyping arrayD S Fleming, J E Koltes, A D Markey, et al.
Molecular Pharmacology|October 1, 1990
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding siteB M Baron, B L Harrison, F P Miller, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
European Journal of Pharmacology|September 22, 1992
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamineC J Schmidt, C K Black, V L Taylor, et al.
Animal Genetics|October 13, 2018
FAANG, establishing metadata standards, validation and best practices for the farmed and companion animal communityP W Harrison, J Fan, D Richardson, et al.
Pharmacology, Biochemistry, and Behavior|July 27, 1999
Pyridostigmine bromide alters locomotion and thigmotaxis of rats: gender effectsJ B Hoy, B A Cody, J L Karlix, et al.
Psychopharmacology|January 1, 1993
Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic functionM G Palfreyman, C J Schmidt, S M Sorensen, et al.
Forensic Science International|April 2, 2016
Fluorescently labeled bacteria provide insight on post-mortem microbial transmigrationZ M Burcham, J A Hood, J L Pechal, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studiesS M Sorensen, J H Kehne, G M Fadayel, et al.
Magnetic Resonance in Medicine|April 16, 1999
Measurement of human myocardial perfusion by double-gated flow alternating inversion recovery EPIB P Poncelet, T M Koelling, C J Schmidt, et al.
Neuroscience|September 25, 2012
The distribution of phosphodiesterase 2A in the rat brainD T Stephenson, T M Coskran, M P Kelly, et al.
BMC Genomics|May 28, 2016
Genomic analysis of Ugandan and Rwandan chicken ecotypes using a 600 k genotyping arrayD S Fleming, J E Koltes, A D Markey, et al.
Molecular Pharmacology|October 1, 1990
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding siteB M Baron, B L Harrison, F P Miller, et al.
Pageof 12